Skip to main content
. Author manuscript; available in PMC: 2009 Jul 20.
Published in final edited form as: Cancer Lett. 2007 Mar 8;253(2):258–264. doi: 10.1016/j.canlet.2007.01.023

Table 1.

Proportion of K-ras positivity in stool from positive FOBT cards with amplified DNA, by type of finding in the colon

Finding in colon Number of cases with positive FOBT and DNA amplification Number of cases with K-ras mutation Proportion of K-ras positivity
Carcinoma+ Adenoma 48 16 33.0%
 Adenocarcinoma 23 8 34.8%
 Adenoma 25 8 32.0%
All other* 82 16 19.5%
No follow up 50 7 14.0%
Total positive FOBT 180 39 21.7%
*

Includes non-adenomatous polyps, diverticuli, IBD, hemorrhoids and upper GI findings